Football
Bad news for Neymar as Barcelona rules out his return
The former Brazilian captain has been pining for a return to the Camp Nou, two years after he
ditched Barcelona for Paris Saint Germaine in a world record transfer fee of £198million.
Neymar has reportedly grown dissatisfied with life at Parc des Princes and has been determined
to leave this summer after yet another disappointing UEFA Champions League campaign.
However, optimism about a potential return to Barcelona has disappeared in recent weeks, with
PSG reluctant to do business with Barcelona.
The la liga giant’s vice president, Jordi Cardoner ruled out Neymar’s return while speaking at the
unveiling of Barcelona’s newest signing, Junior Firpo. According to Cardoner: “As of today,
there’s no Neymar case, as the president said, and it’s complicated.
“We are passive actors. We know he’s not happy in Paris and it’s a situation that needs to be
resolved in Paris.
“We haven’t spoken to them. There is a lot of respect between the clubs and if there is a Neymar
case one day, we’ll talk. Today, at this time, it’s ruled out.”
PSG will only consider selling Neymar back to the Camp Nou if Barcelona produce an offer of
£200m for the want-away Brazilian.
Such a sizeable bid is impossible for Barcelona this summer especially after the club spent
£105m in a deal to land Antoine Greizman from Atletico Madrid.
-
Features7 days agoHow ADC leadership crisis put Atiku’s 2027 ambition at risk
-
Energy7 days agoNNPC plans 5–10% stock market listing, targets 2027 for IPO preparations
-
Business1 week agoLoveWorld Expo 2026 to showcase global innovations, emerging technologies in Lagos
-
Business4 days agoDisCos urge Minister to end blame game, apologise to Nigerians over blackouts
-
Latest7 days ago2027: No Court rulings can keep me off the ballot, Atiku insists
-
Latest1 week agoNDC faults Tinubu’s $7.7bn external loan request, raises debt concerns
-
Latest1 week ago2027: Wike declares Obi’s political wave dead, dismisses chances of presidential victory
-
Health5 days agoStudy links Pfizer COVID-19 vaccine to higher death rates than Moderna shot


